Physiomics Share Discussion Threads

[spacedust] 02/11/2018 10:21

Time will tell.

Are we about to see another huge spike in PYC??? If share price reaches 4.5p then graphs looks poised for 7.5p

[cinquepercento] 02/11/2018 08:53

Spacedust.

Lots of share movement on LAM yesterday for a change.

I think that we might see some significant movement up or down soon.

It may have bottomed out or it is preparing to dive. :-)

[spacedust] 02/11/2018 08:37

He has 2.999999%

[badger60] 30/10/2018 21:10

I hearPwhite73 reckons this has bottomed out and is now a buy. Davevt is still talking it down so that he can pick up a few cheapos... stupid boy!!!

[badger60] 30/10/2018 17:48

Oi davevt.....this is great news....a huge buy in my book.... you stupid boy!!!Chairman and Chief Executive Officer's StatementIntroductionWe are very pleased to report on a year when we generated the highest total income in the Company's history. Having secured the agreement with Merck KGaA in November 2017, we were able to turn our attention to our pipeline and, leveraging the publicity generated by the Merck deal we converted two large pharmaceutical clients and a biotech client in the second half of the financial year, with a further biotech client landing after the year end.In addition, the Company won a second Innovate UK grant in consecutive years in the field of personalised cancer treatment targeting prostate cancer.

[badger60] 30/10/2018 17:41

Oil davevt!!.....Im hearing that PYC is a huge recovery stock buy at these levels......what do you reckon?......stupid boy!!!

[badger60] 30/10/2018 17:26

Davevt......How many more times, Hemogenyx does not trade on the AIM market......you stupid boy!!!!Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx, commented: "The successful Admission to the Main Market will support us through the next growth phase as we work hard to complete the IND application for our lead product, the CDX bi-specify antibody. We believe we have a de-risked, well protected product, and this coupled with an experienced management team and stellar advisory board will help us drive the development of our new treatments forward so we can help address the pressing issue of blood cancers that are currently affecting 1.1 million people in the US alone."

[the stigologist] 30/10/2018 15:21

Not worth wasting your time with £500 trader (probably £250 after his MAFL disaster) like Dave. Just filter him.

[badger60] 30/10/2018 13:43

Could someone tell davevt that Hemogenyx is not an AIM listed company.

[badger60] 30/10/2018 13:30

Are you there Dave?

[davevt] 26/10/2018 12:26

Yeah I know space, I was replying to him

[spacedust] 26/10/2018 11:17

Couple more tick ups will bring it closer to cunningham sell price target to sell his free shares

[spacedust] 26/10/2018 10:58

My post was related to the other poster who said contract value would double.

Pyc are basically a calculator we used to use when in school in the 90s with 'cos sin and tan' on the buttons but from a clinical dosage prediction perspective

[davevt] 25/10/2018 23:27

They can't double the contract value, unless they had twice the drugs to dose predict for, at clinical stage.

I don't think you understand what this company does. You can't just 'choose to spend' more. The revenue is directly related to how many drugs they have to test.

On the contract they were doing clinical trial dosing, about 150k a drug, 3 drugs, 500k. Previous to that is pre clinical trials for said drugs, about 35 grand a pop.

We know what revenues pyc did before this, we can work out how many trials they did, there are no more significant revenues from Merck Even if they have new drugs to test, you're back to pre clinical which is only 35 grand a pop.

Even a brand new customer can't go to pyc for clinical, they all have to start pre clinical. That's why people saying 'imagine if Glaxo was a customer' are idiots. Firstly they may one have one drug to test, they aren't designing them every month, and that's 35 grand.....and about a year to see if it's a success. That's why Merck has taken SIX years to get to clinical trials with pyc. Any new customer will be many years till they are throwing even 150k at pyc, and that's why pyc has always turned over less than your local pub.

[spacedust] 25/10/2018 09:51

Do8vling contract value ....if that is on target then ibexoect the price to rise to at least 12p. It will not go to 32p even if we get a 2m deal

[on target] 25/10/2018 09:26

But keep up the good work.

[on target] 25/10/2018 09:24

I've heard they will be doubling the contract value this time dave.

[davevt] 25/10/2018 08:42

Renew what? It's not a '500k contract', it was a bunch of work to the value of 500k, mainly clinical trials on the previous drugs they ran pre clinical trials on. If this year they only have a couple of new drugs to start dosage predictions on, then it can be 70k again.

[fqr714bhp] 25/10/2018 08:11

davevt: They will renew. LOL!!!!

Be positive dude.

IMHO.